Suppr超能文献

动物血浆中凝血酶生成的比较:对人因子 XIa 和组织因子的敏感性。

Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor.

机构信息

Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.

出版信息

Int J Mol Sci. 2023 Aug 18;24(16):12920. doi: 10.3390/ijms241612920.

Abstract

Preclinical evaluation of drugs in animals helps researchers to select potentially informative clinical laboratory markers for human trials. To assess the utility of animal thrombin generation (TG) assay, we studied the sensitivity of animal plasmas to triggers of TG, human Tissue Factor (TF), and Activated Factor XI (FXIa). Pooled human, mouse, rat, guinea pig, rabbit, bovine, sheep, and goat plasmas were used in this study. TF- or FXIa-triggered TG and clotting were measured via fluorescence and optical density, respectively. Thrombin peak height (TPH) and time (TPT), clot time (CT), and fibrin clot density (FCD) were all analyzed. The trigger low and high sensitivity borders (LSB and HSB) for each assay parameter were defined as TF and FXIa concentrations, providing 20 and 80% of the maximal parameter value, unless the baseline (no trigger) value exceeded 20% of the maximal, in which case, LSB was derived from 120% of baseline value. Normal human samples demonstrated lower TPH HSB than most of the animal samples for both TF and FXIa. Animal samples, except mice, demonstrated lower TPT LSB for FXIa versus humans. Most rodent and rabbit samples produced baseline TG in the absence of TG triggers that were consistent with the pre-activation of blood coagulation. FCD was not sensitive to both TF and FXIa in either of the plasmas. Animal plasmas have widely variable sensitivities to human TF and FXIa, which suggests that optimization of trigger concentration is required prior to test use, and this complicates the extrapolation of animal model results to humans.

摘要

在动物中进行药物的临床前评估有助于研究人员选择有潜力的、可用于人体临床试验的实验室标志物。为了评估动物凝血酶生成(TG)测定的实用性,我们研究了动物血浆对 TG 触发物、人组织因子(TF)和活化因子 XI(FXIa)的敏感性。在这项研究中使用了人、鼠、大鼠、豚鼠、兔、牛、羊和山羊的混合血浆。通过荧光和光密度分别测量 TF 或 FXIa 触发的 TG 和凝固。分析了凝血酶峰高度(TPH)和时间(TPT)、凝固时间(CT)和纤维蛋白凝块密度(FCD)。将各测定参数的低和高灵敏度边界(LSB 和 HSB)定义为 TF 和 FXIa 浓度,提供最大参数值的 20%和 80%,除非基线(无触发)值超过最大参数值的 20%,在这种情况下,LSB 源自基线值的 120%。正常的人样本在 TF 和 FXIa 两种情况下,TPH 的 HSB 均低于大多数动物样本。与人类相比,除了小鼠之外,大多数啮齿动物和兔样本的 FXIa 显示出 TPT 的 LSB 更低。在没有 TG 触发物的情况下,大多数啮齿动物和兔样本的基线 TG 产生,这与血液凝固的预先激活一致。在任何一种血浆中,FCD 对 TF 和 FXIa 都不敏感。动物血浆对人 TF 和 FXIa 的敏感性差异很大,这表明在使用之前需要优化触发物浓度,这使得将动物模型结果推断至人类变得复杂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/870e/10454801/3bd247d4ce99/ijms-24-12920-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验